Results 1 to 10 of about 603 (207)

Carrion's Disease: More Than a Sand Fly-Vectored Illness. [PDF]

open access: yesPLoS Pathogens, 2016
Carrion’s disease is a biphasic illness (S1 Fig) caused by an infection of Bartonella bacilliformis, a bacterium that is transmitted through bites of certain phlebotomine sand flies in the Andean valleys of Peru and in some areas of Ecuador and southern ...
Maria J Pons   +3 more
doaj   +11 more sources

Carrion's disease after blood transfusion. [PDF]

open access: yesBlood Transfus, 2016
Bartonella bacilliformis is a pathogen that is endemic in some areas of the Andean region of Peru, southern Ecuador and southern Colombia. This pathogen causes so-called Carrion's disease, a biphasic disease with acute and chronic phases (called Oroya ...
Pons MJ   +5 more
europepmc   +9 more sources

Carrion’s disease: more than a neglected disease [PDF]

open access: yesParasites & Vectors, 2019
Infections with Bartonella bacilliformis result in Carrion’s disease in humans. In the first phase of infection, the pathogen causes a hemolytic fever (“Oroya fever”) with case-fatality rates as high as ~90% in untreated patients, followed by a chronical
Meritxell Garcia-Quintanilla   +3 more
doaj   +4 more sources

Carrion's disease: an eradicable illness? [PDF]

open access: yesInfect Dis Poverty, 2016
Carrion's disease is a neglected tropical disease caused by Bartonella bacilliformis, a vector-borne pathogen restricted to the Andean valleys of Peru, Ecuador and Colombia.
Gomes C   +3 more
europepmc   +10 more sources

Immunosuppressive and angiogenic cytokine profile associated with Bartonella bacilliformis infection in post-outbreak and endemic areas of Carrion's disease in Peru. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2017
Analysis of immune responses in Bartonella bacilliformis carriers are needed to understand acquisition of immunity to Carrion's disease and may allow identifying biomarkers associated with bacterial infection and disease phases.
Maria J Pons   +8 more
doaj   +7 more sources

An unidentified cluster of infection in the Peruvian Amazon region [PDF]

open access: yesJournal of Infection in Developing Countries, 2015
Introduction: Bartonella bacilliformis is the etiological agent of Carrion’s disease, which is a neglected disease linked to people in low-socioeconomic populations in Andean valleys. An outbreak of B.
Angela Cornejo   +7 more
doaj   +5 more sources

Succinyl-CoA Synthetase: New Antigen Candidate of Bartonella bacilliformis. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2016
Bartonella bacilliformis is the causative agent of Carrion's disease, a neglected illness with mortality rates of 40-85% in the absence of treatment. The lack of a diagnostic technique to overcome misdiagnosis and treat asymptomatic carriers is of note ...
Cláudia Gomes   +9 more
doaj   +4 more sources

Diagnosis of Carrion's disease by direct blood PCR in thin blood smear negative samples. [PDF]

open access: yesPLoS ONE, 2014
Bartonella bacilliformis is the etiologic agent of Carrion's disease. This disease has two well established phases, the most relevant being the so called Oroya Fever, in which B.
Juana del Valle Mendoza   +10 more
doaj   +2 more sources

Carrion's Disease: the Sound of Silence. [PDF]

open access: yesClin Microbiol Rev, 2018
SUMMARYCarrion's disease (CD) is a neglected biphasic vector-borne illness related toBartonella bacilliformis. It is found in the Andean valleys and is transmitted mainly by members of theLutzomyiagenus but also by blood transfusions and from mother to child. The acute phase, Oroya fever, presents severe anemia and fever.
Gomes C, Ruiz J.
europepmc   +4 more sources

Baculovirus-Assisted Production of Bartonella bacilliformis Proteins: A Potential Strategy for Improving Serological Diagnosis of Carrion’s Disease [PDF]

open access: yesPathogens
Carrion’s disease, caused by Bartonella bacilliformis, is a neglected tropical disease prevalent in the Andean region of South America. Without antimicrobial treatment, this disease has a mortality rate of up to 88% in infected patients.
Lizbeth Sally Vilca-Machaca   +5 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy